Taken together, these findings demonstrate that RH accelerates the progression of AD-type pathologies and cognitive deficits in STZ-induced APP/PS1-DM mice by inhibiting GLUT3-mediated glucose uptake. This evidence concerns the gene APP and Alzheimer disease.